Novo Nordisk (ADR) Live Stock Price Today, Share Analysis and Chart

Name: Novo Nordisk - ADR: Is Infosys Ltd. worth buying?
Item: Novo Nordisk - ADR
Rating: 1.641263875
Author: Trendlyne DVM scores

Await Turnaround

about

With roughly one-third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, inject...

44.39 0.51 (1.16%)

45.49% Fall from 52W High

18.6M

XNYS Volume

XNYS 04 May, 2026 5:30 PM (EDT)

Board Meeting

The next board meeting for Novo Nordisk (ADR) is on 07 May 2026 for the purpose of Novo Nordisk AS First Quarter Earnings Results for 2026 See details

Low Financial Strength

22.2 / 100

Mid Valuation

37.7 / 100

Technically Neutral

49.2 / 100

Await Turnaround These stocks have poor financials and average valuation and momentum. Investors should be cautious about these stocks View Similar Embed DVM

1Yr Price target upside is 5%

12 analysts

Novo Nordisk (ADR) Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..